Skip to content

Effects of Different Surgical Methods to Treat Obesity

Metabolic Effects of Different Surgical Methods to Treat Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01785134
Acronym
DEOSH
Enrollment
81
Registered
2013-02-07
Start date
2006-05-31
Completion date
2011-12-31
Last updated
2014-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Type 2 Diabetes, Insulin Sensitivity

Keywords

Obesity, Bariatric Surgery, Insulin Sensitivity

Brief summary

Obese patients have an increased risk for developing severe metabolic disorders. This risk can only partly be reduced by weight reduction. The investigators have in a pilot study investigated if removal of abdominal fat (visceral) in addition to weight loss has additional beneficial effects on the metabolic profile and weight loss. This study aims to further investigate if removal of abdominal fat (major omentum) leads to beneficial metabolic effects.

Interventions

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
The Swedish Research Council
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Body mass index over 40 kg/m2 Body mass index over 35 kg/m2 with obesity associated co-morbidities such as type 2 diabetes and/or additional cardiovascular risk factors -

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Insulin Sensitivity at 2 Years2 years postoperativeInsulin sensitivity measured by hyperinsulinemic euglycemic clamp

Secondary

MeasureTime frame
Body Composition at Two Years2 years postoperative
Blood Pressure at 2 Years2 years postoperative
Body Mass Index at 2 Years2 years postoperative
Blood Lipids2 years postoperative

Countries

Sweden

Participant flow

Participants by arm

ArmCount
Control
Gastric bypass operation without omentectomy. Gastric bypass operation
41
Omentectomy
Gastric bypass operation in conjunction with removal of greater omentum Omentectomy Gastric bypass operation
40
Total81

Baseline characteristics

CharacteristicControlOmentectomyTotal
Age, Continuous41 years
STANDARD_DEVIATION 9
43 years
STANDARD_DEVIATION 9
42 years
STANDARD_DEVIATION 9
Region of Enrollment
Sweden
41 participants40 participants81 participants
Sex: Female, Male
Female
41 Participants40 Participants81 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 410 / 40
serious
Total, serious adverse events
0 / 410 / 40

Outcome results

Primary

Insulin Sensitivity at 2 Years

Insulin sensitivity measured by hyperinsulinemic euglycemic clamp

Time frame: 2 years postoperative

ArmMeasureValue (MEAN)Dispersion
ControlInsulin Sensitivity at 2 Years6.7 glucose/kg body weight/minStandard Deviation 1.6
OmentectomyInsulin Sensitivity at 2 Years6.6 glucose/kg body weight/minStandard Deviation 1.5
Secondary

Blood Lipids

Time frame: 2 years postoperative

ArmMeasureValue (MEAN)Dispersion
ControlBlood Lipids4.0 P-Cholesterol mmol/LStandard Deviation 0.9
OmentectomyBlood Lipids4.2 P-Cholesterol mmol/LStandard Deviation 0.8
Secondary

Blood Pressure at 2 Years

Time frame: 2 years postoperative

ArmMeasureValue (MEAN)Dispersion
ControlBlood Pressure at 2 Years123 mm Hg systolicStandard Deviation 16
OmentectomyBlood Pressure at 2 Years121 mm Hg systolicStandard Deviation 23
Secondary

Body Composition at Two Years

Time frame: 2 years postoperative

ArmMeasureValue (MEAN)Dispersion
ControlBody Composition at Two Years36 % body fatStandard Deviation 8
OmentectomyBody Composition at Two Years38 % body fatStandard Deviation 8
Secondary

Body Mass Index at 2 Years

Time frame: 2 years postoperative

ArmMeasureValue (MEAN)Dispersion
ControlBody Mass Index at 2 Years28.6 Kg/meter squaredStandard Deviation 4.6
OmentectomyBody Mass Index at 2 Years28.9 Kg/meter squaredStandard Deviation 4.3

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026